<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04158388</url>
  </required_header>
  <id_info>
    <org_study_id>UA-2019-04-10</org_study_id>
    <nct_id>NCT04158388</nct_id>
  </id_info>
  <brief_title>Effects of Nutritional Strategies or Manual Therapies in Women With Fibromyalgia</brief_title>
  <official_title>Effects of Nutritional Strategies or Manual Therapies on Physical and Psychological Parameters in Women With Fybromyalgia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alicante</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alicante</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study had two objectives. The first main aim was to analyze the effects of tryptophan and
      magnesium-enriched Mediterranean diet on psychological variables (trait anxiety, self-image,
      mood state, eating disorders) and sleep effects in women with fibromyalgia. Our hypothesis,
      based on previous positive effects of tryptophan and magnesium supplementation by separate in
      this population, may improve psychological health and regulate sleep disruptions. The second
      aim was to assess the effectiveness of a manual therapy technique performed with moderate
      digital pressure in fibromyalgia patients on the variables of fatigue, pain, sleep, anxiety
      and mood. It was done to provide an alternative treatment to pharmacological therapies for
      fibromyalgia patients and to provide new evidence on the effects of manual therapy in
      fibromyalgia patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Actual">October 10, 2019</completion_date>
  <primary_completion_date type="Actual">October 9, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sleep Quality</measure>
    <time_frame>4 - 16 weeks</time_frame>
    <description>Sleep Quality assessment: Athenas Insomnia Scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anxiety trait</measure>
    <time_frame>4 - 16 weeks</time_frame>
    <description>Anxiety trait assessment: Stay Trait Anxiety Inventory.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mood state</measure>
    <time_frame>4 - 16 weeks</time_frame>
    <description>Mood state assessment: Profile of Mood State inventory.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fatigue severity</measure>
    <time_frame>4 - 16 weeks</time_frame>
    <description>Fatigue severity assessment: Fatigue Severity Scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain perception</measure>
    <time_frame>4 - 16 weeks</time_frame>
    <description>Pain perception assessment: Visual Analogical Scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep quality</measure>
    <time_frame>4 - 16 weeks</time_frame>
    <description>Sleep quality assessment: Pittsburgh Sleep Quality Index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>4 - 16 weeks</time_frame>
    <description>Body composition assessment trough bioimpedance.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Fibromyalgia</condition>
  <arm_group>
    <arm_group_label>EXPERIMENTAL DIET GROUP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL GROUP</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>EXPERIMENTAL MASSAGE GROUP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>That group received moderate pressure digital manual therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EXPERIMENTAL PLACEBO GROUP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>That group was treated with a US (in off mode) without conductive gel. Placebo group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mediterranean-diet enriched with a higher dose of tryptophan and magnesium</intervention_name>
    <description>That gruop eaten at both breakfast and dinner from walnuts (3-5 units), as food with high values of tryptophan and magnesium</description>
    <arm_group_label>EXPERIMENTAL DIET GROUP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Isocaloric diet</intervention_name>
    <description>That group eaten isocaloric diet plan based on Mediterranean diet.</description>
    <arm_group_label>CONTROL GROUP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Manual therapy</intervention_name>
    <description>That group received moderate pressure digital manual therapy.</description>
    <arm_group_label>EXPERIMENTAL MASSAGE GROUP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo therapy</intervention_name>
    <description>That group was treated with a US (in off mode) without conductive gel.</description>
    <arm_group_label>EXPERIMENTAL PLACEBO GROUP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Women aged 40-60 with fibromialgia (officially diagnosed).

        Exclusion Criteria:

          -  Women used analgesics, vitamins containing supplements, and or other drugs for the
             treatment of fibromyalgia symptoms, or participation in other clinical trials.

          -  Women that be performing simultaneously to this study some other physical therapy or
             physical exercise treatment. Not having sufficient cognitive level to collaborate in
             the study or not having the possibility of attending the established sessions.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Alicante</name>
      <address>
        <city>Alicante</city>
        <state>San Vicente Del Raspeig</state>
        <zip>03690</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>October 14, 2019</study_first_submitted>
  <study_first_submitted_qc>November 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2019</study_first_posted>
  <last_update_submitted>May 8, 2020</last_update_submitted>
  <last_update_submitted_qc>May 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alicante</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Alejandro Martínez-Rodríguez</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>micronutrients</keyword>
  <keyword>nutrition</keyword>
  <keyword>therapy</keyword>
  <keyword>chronic disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tryptophan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

